Gut microbiome-derived secondary bile acids: therapeutic targets for reducing cardiovascular disease in type 2 diabetes?

Am J Clin Nutr. 2024 Feb;119(2):241-243. doi: 10.1016/j.ajcnut.2023.09.017. Epub 2023 Oct 19.

Authors

Sarah A Johnson¹, Tiffany L Weir²

Affiliations

¹ Department of Food Science and Human Nutrition, Colorado State University, Fort Collins, CO, United States. Electronic address: Sarah.Johnson@colostate.edu.
² Department of Food Science and Human Nutrition, Colorado State University, Fort Collins, CO, United States.

PMID: 38309821
DOI: 10.1016/j.ajcnut.2023.09.017

No abstract available

Publication types

Editorial

MeSH terms

Bile Acids and Salts
Cardiovascular Diseases* / prevention & control
Diabetes Mellitus, Type 2* / complications
Diabetes Mellitus, Type 2* / drug therapy
Gastrointestinal Microbiome*
Humans

Substances

Bile Acids and Salts